|
US8295A
(en)
|
|
1851-08-12 |
|
Construction- of roofs |
|
SU1138164A1
(ru)
|
1963-04-25 |
1985-02-07 |
Shadurskij Konstantin S |
Антигистаминное средство "димебон
|
|
US4407957A
(en)
|
1981-03-13 |
1983-10-04 |
Damon Corporation |
Reversible microencapsulation of a core material
|
|
FI844786A0
(fi)
|
1984-12-04 |
1984-12-04 |
Farmos Oy |
Terapeutiskt utnyttjbar foerening.
|
|
US4839170A
(en)
|
1985-10-01 |
1989-06-13 |
Survival Technology, Inc. |
Protein absorption enhancing agents
|
|
US4760094A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US4767789A
(en)
|
1986-10-21 |
1988-08-30 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US4760093A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
|
US5039540A
(en)
|
1989-08-14 |
1991-08-13 |
Neophore Technologies, Inc. |
Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
|
|
US5217718A
(en)
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5215756A
(en)
|
1989-12-22 |
1993-06-01 |
Gole Dilip J |
Preparation of pharmaceutical and other matrix systems by solid-state dissolution
|
|
US5188825A
(en)
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
|
ATE156344T1
(de)
|
1991-04-25 |
1997-08-15 |
Univ Brown Res Found |
Implantierbare, biokompatible immunisolator- trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte
|
|
US5352456A
(en)
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
PT679088E
(pt)
|
1992-09-29 |
2002-12-31 |
Inhale Therapeutic Syst |
Administracao pulmonar de fragmentos activos de hormona paratiroide
|
|
US5343672A
(en)
|
1992-12-01 |
1994-09-06 |
Scherer Ltd R P |
Method for manufacturing freeze dried dosages in a multilaminate blister pack
|
|
ATE208615T1
(de)
|
1993-07-09 |
2001-11-15 |
Scherer Corp R P |
Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
|
|
GB2281206A
(en)
|
1993-08-25 |
1995-03-01 |
Orion Yhtymae Oy |
Use of dexmedetomidine
|
|
US5457895A
(en)
|
1993-10-01 |
1995-10-17 |
R. P. Scherer Corporation |
Method of identifying freeze-dried dosage forms
|
|
US5508367A
(en)
|
1993-11-29 |
1996-04-16 |
Adhesives Research, Inc. |
Water-soluble pressure sensitive adhesive
|
|
US5395907A
(en)
|
1993-11-29 |
1995-03-07 |
Adhesive Research, Inc. |
Water-soluble pressure sensitive adhesive
|
|
ATE176796T1
(de)
|
1993-11-29 |
1999-03-15 |
Adhesives Res Inc |
Wasserlöslicher, druckempfindlicher klebstoff
|
|
FR2718357B1
(fr)
|
1994-04-06 |
1997-10-03 |
Defarges Alain Moreau |
Perfectionnements apportés à un dispositif d'injection par jet sans aiguille.
|
|
GB2290964A
(en)
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
|
US5731387A
(en)
|
1994-07-11 |
1998-03-24 |
Adhesives Research, Inc. |
Ionically-crosslinked water-absorbent graft copolymer
|
|
US5726250A
(en)
|
1994-07-11 |
1998-03-10 |
Adhesives Research, Inc. |
Covalently crosslinked water-absorbent graft copolymer
|
|
US6726928B2
(en)
|
1994-10-28 |
2004-04-27 |
R.P. Scherer Technologies, Inc. |
Process for preparing solid dosage forms for unpalatable pharmaceuticals
|
|
GB9421836D0
(en)
|
1994-10-28 |
1994-12-14 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
|
|
US5837287A
(en)
|
1994-10-28 |
1998-11-17 |
R P Scherer Corporation |
Process for preparing solid pharmaceutical dosage forms
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5605911A
(en)
|
1995-01-31 |
1997-02-25 |
Washington University |
Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
|
|
US5700873A
(en)
|
1995-03-07 |
1997-12-23 |
Adhesives Research, Inc. |
Method of preparation of water-soluble copolymer
|
|
US5780014A
(en)
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
|
US5654007A
(en)
|
1995-06-07 |
1997-08-05 |
Inhale Therapeutic Systems |
Methods and system for processing dispersible fine powders
|
|
GB9616672D0
(en)
|
1996-08-08 |
1996-09-25 |
Scherer Ltd R P |
Pharmaceutical compositions
|
|
US5800832A
(en)
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
|
GB9700624D0
(en)
|
1997-01-14 |
1997-03-05 |
Danbiosyst Uk |
Drug delivery composition
|
|
GB9702799D0
(en)
|
1997-02-12 |
1997-04-02 |
Scherer Corp R P |
Process for preparing solid pharmaceutical dosage forms
|
|
WO1998036738A1
(en)
|
1997-02-20 |
1998-08-27 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
|
WO1998037111A1
(en)
|
1997-02-21 |
1998-08-27 |
Adhesives Research, Inc. |
Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
|
|
US5951999A
(en)
|
1997-02-21 |
1999-09-14 |
Adhesives Research, Inc. |
Transdermal pressure sensitive adhesive drug delivery system
|
|
US6239228B1
(en)
|
1997-02-21 |
2001-05-29 |
Adhesives Research, Inc. |
Pressure sensitive adhesive containing macromer having repeat hydrophilic moieties
|
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
US5976577A
(en)
|
1997-07-11 |
1999-11-02 |
Rp Scherer Corporation |
Process for preparing fast dispersing solid oral dosage form
|
|
EP1001748B1
(en)
|
1997-07-25 |
2006-04-19 |
Alpex Pharma S.A. |
A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
|
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
|
GB9802088D0
(en)
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
|
ATE370889T1
(de)
|
1998-03-09 |
2007-09-15 |
Cima Labs Inc |
Vorrichtung zum handhaben und verpacken von spröden tabletten
|
|
US6200604B1
(en)
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US6716867B1
(en)
*
|
1998-04-01 |
2004-04-06 |
Orion Corporation |
Use of dexmedetomidine for ICU sedation
|
|
AU2005201500B2
(en)
|
1998-06-03 |
2007-01-04 |
Scott Laboratories, Inc. |
Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
|
|
US7565905B2
(en)
|
1998-06-03 |
2009-07-28 |
Scott Laboratories, Inc. |
Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness
|
|
CN1311877C
(zh)
|
1998-06-03 |
2007-04-25 |
斯科特实验室公司 |
为患者缓解与内科或外科处理相关的痛苦的设备和方法
|
|
US7001609B1
(en)
|
1998-10-02 |
2006-02-21 |
Regents Of The University Of Minnesota |
Mucosal originated drug delivery systems and animal applications
|
|
PL201578B1
(pl)
|
1998-11-20 |
2009-04-30 |
Skyepharma Canada Inc |
Stała terapeutyczna postać dawkowania nierozpuszczalnego lub słabo rozpuszczalnego w wodzie związku
|
|
GB9901819D0
(en)
|
1999-01-27 |
1999-03-17 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
|
DE19940740A1
(de)
|
1999-08-31 |
2001-03-01 |
Gruenenthal Gmbh |
Pharmazeutische Salze
|
|
US6984207B1
(en)
|
1999-09-14 |
2006-01-10 |
Hoana Medical, Inc. |
Passive physiological monitoring (P2M) system
|
|
CA2324967A1
(en)
|
2000-11-01 |
2002-05-01 |
3816133 Canada Inc. |
System for monitoring patients with alzheimer's disease or related dementia
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
ATE478932T1
(de)
|
2000-07-07 |
2010-09-15 |
Av Topchiev Inst Petrochemical |
Herstellung von hydrophilen druckempfindlichen klebstoffen mit optimalen hafteigenschaften
|
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
US6814978B2
(en)
|
2000-12-29 |
2004-11-09 |
Mcneil-Ppc, Inc. |
Process for preparing a soft tablet
|
|
WO2002089794A1
(en)
|
2001-05-07 |
2002-11-14 |
Universite Catholique De Louvain |
Method for treating neuropathic pain and pharmaceutical preparation therefor
|
|
US20030083822A2
(en)
|
2001-05-15 |
2003-05-01 |
Psychogenics, Inc. |
Systems and methods for monitoring behavior informatics
|
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US20140271788A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
|
ATE371442T1
(de)
|
2001-10-12 |
2007-09-15 |
Elan Pharma Int Ltd |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
FR2832311B1
(fr)
|
2001-11-21 |
2004-04-16 |
Besins Int Belgique |
Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
|
|
FR2834212B1
(fr)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
EP1485296B1
(en)
|
2002-02-13 |
2011-07-20 |
Michael K. Weibel |
Drug dose - form and method of manufacture
|
|
WO2004032913A1
(en)
|
2002-10-08 |
2004-04-22 |
Allergan, Inc. |
Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of neurodegeneration
|
|
US20040156894A1
(en)
|
2003-02-07 |
2004-08-12 |
Grother Leon Paul |
Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
|
|
EP3210601A1
(en)
|
2003-05-28 |
2017-08-30 |
MonoSolRX, LLC |
Polyethylene oxide-based films and drug delivery system made therefrom
|
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
|
AU2004283721B2
(en)
|
2003-10-24 |
2009-08-13 |
Adhesives Research, Inc. |
Rapidly disintegrating film
|
|
US9248146B2
(en)
|
2003-10-24 |
2016-02-02 |
Adhesives Research, Inc. |
Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
|
|
GB0403808D0
(en)
|
2004-02-20 |
2004-03-24 |
Bioprogress Technology Ltd |
Films for use as dosage forms
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
US7972621B2
(en)
|
2004-06-03 |
2011-07-05 |
R.P. Scherer Technologies, Llc |
Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
|
|
US20060058590A1
(en)
|
2004-08-24 |
2006-03-16 |
Shaw Geoffrey M |
Method and system for assaying agitation
|
|
US20060058700A1
(en)
|
2004-08-26 |
2006-03-16 |
Marro Dominic P |
Patient sedation monitor
|
|
US20060069086A1
(en)
|
2004-09-23 |
2006-03-30 |
Alexander Michalow |
Methods for regulating neurotransmitter systems by inducing counteradaptations
|
|
US20080214903A1
(en)
|
2005-02-22 |
2008-09-04 |
Tuvi Orbach |
Methods and Systems for Physiological and Psycho-Physiological Monitoring and Uses Thereof
|
|
CA2599937A1
(en)
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
|
|
WO2007010242A1
(en)
|
2005-07-18 |
2007-01-25 |
Imperial College Innovations Limited |
Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
|
|
US20070106126A1
(en)
|
2005-09-30 |
2007-05-10 |
Mannheimer Paul D |
Patient monitoring alarm escalation system and method
|
|
CA2624731A1
(en)
|
2005-10-04 |
2007-04-12 |
Medivation, Inc. |
Hydrogenated pyrido-indole compounds for the treatment of huntington's disease
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
WO2007074472A2
(en)
|
2005-12-27 |
2007-07-05 |
Jubilant Organosys Limited |
Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide
|
|
EP2526943B1
(en)
|
2006-02-13 |
2017-03-22 |
Orient Pharma (Samoa) Co, Ltd |
Liquid formulation comprising an alpha-2 receptor agonist (e.g. clonidin) and oxybutynin (anti-muscarinic agent) for the treatment of sialorrhoea
|
|
US7630758B2
(en)
|
2006-06-22 |
2009-12-08 |
General Electric Company |
Separation of natural and drug-induced sleep of a subject
|
|
US20080026040A1
(en)
|
2006-07-31 |
2008-01-31 |
Isaac Farr |
Active agent-releasing dosage forms
|
|
CN101516331A
(zh)
|
2006-09-20 |
2009-08-26 |
莫诺索尔克斯有限公司 |
含有抗泡沫调味剂的可食用水溶性膜
|
|
US8157730B2
(en)
|
2006-12-19 |
2012-04-17 |
Valencell, Inc. |
Physiological and environmental monitoring systems and methods
|
|
US20080153808A1
(en)
|
2006-12-22 |
2008-06-26 |
Allergan, Inc. |
Alpha-2 receptor pan agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
|
|
US20100028447A1
(en)
|
2007-01-22 |
2010-02-04 |
Targacept, Inc. |
Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
|
|
US8568777B2
(en)
|
2007-03-30 |
2013-10-29 |
Monosol Rx, Llc |
Packaged film dosage unit containing a complexate
|
|
WO2008141264A1
(en)
|
2007-05-10 |
2008-11-20 |
Novadel Pharma Inc. |
Anti-insomnia compositions and methods
|
|
WO2008153754A1
(en)
|
2007-05-24 |
2008-12-18 |
Peter Salgo |
System and method for patient monitoring
|
|
JP5269894B2
(ja)
|
2007-06-27 |
2013-08-21 |
ハンミ ファーム． シーオー．， エルティーディー． |
経口投与用速溶性製剤の製造方法及びその製造、並びに包装装置
|
|
RU2338533C1
(ru)
|
2007-06-28 |
2008-11-20 |
Сергей Олегович Бачурин |
СРЕДСТВО, ОБЛАДАЮЩЕЕ АНКСИОЛИТИЧЕСКИМ ДЕЙСТВИЕМ, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b)ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
|
|
WO2009017836A1
(en)
|
2007-08-01 |
2009-02-05 |
Medivation Neurology, Inc. |
Methods and compositions for treating schizophrenia using antipsychotic combination therapy
|
|
EA021392B1
(ru)
|
2007-10-11 |
2015-06-30 |
Филип Моррис Продактс С.А. |
Бездымный табачный продукт
|
|
US8298583B2
(en)
|
2007-10-19 |
2012-10-30 |
Monosol Rx, Llc |
Film delivery system for tetrahydrolipstatin
|
|
PE20091084A1
(es)
|
2007-12-07 |
2009-07-23 |
Schering Plough Healthcare |
Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
|
|
CN101496801A
(zh)
|
2008-02-02 |
2009-08-05 |
四川百利药业有限责任公司 |
右旋美托咪定及其药用盐的用途
|
|
US20100285134A1
(en)
|
2008-02-15 |
2010-11-11 |
Bone Therepeutics |
Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
|
|
CA2716901C
(en)
|
2008-02-28 |
2018-07-03 |
R.P. Scherer Technologies, Llc |
Process to minimize polymorphism
|
|
US20190216389A1
(en)
|
2008-04-07 |
2019-07-18 |
Christopher Scheib |
Method and system for analyzing a series of electroencephalogram (eeg) signals during altered brain states
|
|
US20090275853A1
(en)
|
2008-04-30 |
2009-11-05 |
The General Electric Company |
Method and apparatus for monitoring physiological state of a subject
|
|
US8882684B2
(en)
|
2008-05-12 |
2014-11-11 |
Earlysense Ltd. |
Monitoring, predicting and treating clinical episodes
|
|
US20100029706A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Parmaceuticals, Inc. a Delaware Corporation |
HYDROGENATED PYRIDO[4,3-b]INDOLES FOR THE TREATMENT OF OXIDATIVE STRESS
|
|
EP2340254B8
(en)
|
2008-09-15 |
2014-05-21 |
Biovista, Inc. |
Compositions and methods for treating epilepsy
|
|
US8545806B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
|
US8849441B2
(en)
|
2008-10-31 |
2014-09-30 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
|
US8470546B2
(en)
|
2008-11-25 |
2013-06-25 |
Albert Einstein College Of Medicine Of Yeshiva University |
Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system
|
|
US20100196286A1
(en)
|
2008-12-01 |
2010-08-05 |
Armer Thomas A |
Inhalation delivery methods and devices
|
|
US8282954B2
(en)
|
2008-12-15 |
2012-10-09 |
Monosol Rx, Llc |
Method for manufacturing edible film
|
|
TR200903014A1
(tr)
|
2009-04-17 |
2010-11-22 |
Sanovel İlaç San. Ve Ti̇c. A.Ş. |
Oral yolla dağılan dimebolin bileşimleri.
|
|
KR101859486B1
(ko)
|
2009-05-15 |
2018-06-28 |
레크로파마, 인코포레이티드 |
설하용 덱스메데토미딘 조성물과 그의 사용 방법
|
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
|
US9775819B2
(en)
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
|
WO2011039686A1
(en)
|
2009-09-30 |
2011-04-07 |
Pfizer Inc. |
Latrepirdine oral sustained release dosage forms
|
|
AU2011204315A1
(en)
|
2010-01-08 |
2012-08-02 |
Recro Pharma, Inc. |
Topical transdermal dexmedetomidine compositions and methods of use thereof
|
|
US20110245633A1
(en)
|
2010-03-04 |
2011-10-06 |
Neumitra LLC |
Devices and methods for treating psychological disorders
|
|
US10548839B2
(en)
|
2010-03-16 |
2020-02-04 |
Wei Tian |
Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
|
|
EP2558101A4
(en)
|
2010-04-15 |
2013-09-18 |
Univ Mcgill |
TOPICAL TREATMENTS OF PAIN
|
|
US9572773B2
(en)
|
2010-04-26 |
2017-02-21 |
Novartis A.G. |
Layered drug delivery device
|
|
US20110290694A1
(en)
|
2010-05-27 |
2011-12-01 |
Monosol Rx, Llc |
Oral film dosage form having indicia thereon
|
|
US8529914B2
(en)
|
2010-06-28 |
2013-09-10 |
Richard C. Fuisz |
Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
|
|
EP2605698B1
(en)
|
2010-08-17 |
2020-04-15 |
University of Florida Research Foundation, Inc. |
Central site photoplethysmography, medication administration, and safety
|
|
CN103298459A
(zh)
|
2010-09-23 |
2013-09-11 |
莫诺索尔克斯有限公司 |
用于直接在包装表面上形成药用产品的方法和系统
|
|
US8383135B2
(en)
|
2010-12-03 |
2013-02-26 |
Richard C. Fuisz |
Solid dosage form that promotes reliable oral, esophageal and GI transit
|
|
EP2651357B1
(en)
|
2010-12-16 |
2020-04-01 |
Sunovion Pharmaceuticals Inc. |
Sublingual films
|
|
US8445526B2
(en)
|
2011-02-03 |
2013-05-21 |
Glaucoma & Nasal Therapies Llc |
Compositions and methods for treatment of glaucoma
|
|
US20140163080A1
(en)
|
2011-02-03 |
2014-06-12 |
Gnt, Llc |
Compositions and Methods for Treatment of Glaucoma
|
|
WO2012104834A1
(en)
|
2011-02-03 |
2012-08-09 |
Pharmedica Ltd. |
New oral dissolving films for insulin administration, for treating diabetes
|
|
WO2016029227A1
(en)
|
2014-08-22 |
2016-02-25 |
The General Hospital Corporation |
Systems and methods for predicting arousal to consciousness during general anesthesia and sedation
|
|
US8241661B1
(en)
|
2011-06-24 |
2012-08-14 |
Fuisz Richard C |
Biocompatible film with variable cross-sectional properties
|
|
US8703697B2
(en)
|
2011-06-24 |
2014-04-22 |
Luc QUINTIN |
Method for treating early severe diffuse acute respiratory distress syndrome
|
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
|
WO2013061161A2
(en)
|
2011-10-28 |
2013-05-02 |
Green Bcn Consulting Services Sl |
New combination therapies for treating neurological disorders
|
|
RU2692245C2
(ru)
|
2011-12-11 |
2019-06-24 |
Рекро Фарма, Инк. |
Интраназальные композиции дексмедетомидина и способы их применения
|
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
|
WO2013130577A2
(en)
|
2012-02-27 |
2013-09-06 |
Eye Therapies, Llc |
Compositions and methods for the treatment of migraine
|
|
JP5921928B2
(ja)
|
2012-03-28 |
2016-05-24 |
テルモ株式会社 |
既希釈デクスメデトミジン製剤
|
|
CN102657635B
(zh)
|
2012-05-04 |
2013-08-07 |
上海现代药物制剂工程研究中心有限公司 |
具有微孔的海绵状的阿塞那平舌下膜剂及其制备方法
|
|
WO2013173317A1
(en)
|
2012-05-14 |
2013-11-21 |
Prospire, Llc |
TREATMENT OF OBSTRUCTIVE SLEEP APNEA WITH α2-ADRENERGIC RECEPTOR AGONISTS
|
|
KR20150059167A
(ko)
|
2012-07-06 |
2015-05-29 |
에갈렛 리미티드 |
제어된 방출을 위한 남용 제지 약학적 조성물
|
|
US10130766B1
(en)
|
2012-08-08 |
2018-11-20 |
Neurowave Systems Inc. |
Intelligent pharmaceutical delivery system with automatic shutoff and method of using
|
|
HUE025008T2
(en)
|
2012-10-12 |
2016-04-28 |
Omya Int Ag |
Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
|
|
US20140180160A1
(en)
|
2012-10-12 |
2014-06-26 |
Emery N. Brown |
System and method for monitoring and controlling a state of a patient during and after administration of anesthetic compound
|
|
DK2906213T3
(en)
|
2012-10-15 |
2018-02-19 |
Orion Corp |
VETERINARY PROCEDURE FOR RELIEFING NOISE SENSITIVITY
|
|
GB2510321B
(en)
|
2012-11-12 |
2018-01-31 |
Biosurgical S L |
Agitation apparatus
|
|
US9545376B2
(en)
|
2013-01-23 |
2017-01-17 |
Arx, Llc |
Production of unit dose constructs
|
|
US9901650B2
(en)
|
2013-02-21 |
2018-02-27 |
University Of Rochester |
Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
|
|
WO2014144365A1
(en)
|
2013-03-15 |
2014-09-18 |
University Of Maryland, College Park |
Nano-liposomal formulations and methods of use
|
|
US20140261990A1
(en)
|
2013-03-15 |
2014-09-18 |
Monosol Rx, Llc |
Multi-layer films having uniform content
|
|
US9303918B2
(en)
|
2013-03-15 |
2016-04-05 |
Monosol Rx, Llc |
Process for drying a wet film with control of loss on drying
|
|
US9346601B2
(en)
|
2013-03-15 |
2016-05-24 |
Monosol Rx, Llc |
Reduction in stress cracking of films
|
|
TWI626289B
(zh)
|
2013-03-22 |
2018-06-11 |
黏合劑研究股份有限公司 |
親水性黏合劑以及含有該親水性黏合劑之帶與元件
|
|
JP2016520375A
(ja)
|
2013-04-23 |
2016-07-14 |
ザ ジェネラル ホスピタル コーポレイション |
脳のコヒーレンスおよびシンクロニーの指標を使用して麻酔および鎮静を監視するためのシステムおよび方法
|
|
WO2014176436A1
(en)
|
2013-04-24 |
2014-10-30 |
The General Hospital Corporation |
System and method for estimating high time-frequency resolution eeg spectrograms to monitor patient state
|
|
WO2014176441A1
(en)
|
2013-04-24 |
2014-10-30 |
The General Hospital Corporation |
System and method for monitoring level of dexmedatomidine-induced sedation
|
|
CN103284945A
(zh)
|
2013-06-03 |
2013-09-11 |
四川百利药业有限责任公司 |
一种预充式盐酸右美托咪定注射液的制备方法
|
|
EP3004224B1
(en)
|
2013-06-04 |
2022-01-26 |
Monosol, LLC |
Water-soluble film sealing solutions, related methods, and related articles
|
|
JP6660878B2
(ja)
|
2013-06-27 |
2020-03-11 |
ザ ジェネラル ホスピタル コーポレイション |
生理学的データにおける動的構造を追跡するためのシステムおよび該システムの作動方法
|
|
US10383574B2
(en)
|
2013-06-28 |
2019-08-20 |
The General Hospital Corporation |
Systems and methods to infer brain state during burst suppression
|
|
EP4166072A1
(en)
|
2013-09-13 |
2023-04-19 |
The General Hospital Corporation |
Systems and methods for improved brain monitoring during general anesthesia and sedation
|
|
EP3054932B1
(en)
|
2013-10-07 |
2020-12-09 |
Teikoku Pharma USA, Inc. |
Dexmedetomidine transdermal delivery devices and methods for using the same
|
|
CN106456561B
(zh)
|
2013-10-07 |
2020-02-28 |
帝国制药美国公司 |
使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
|
|
TWI629061B
(zh)
|
2013-10-07 |
2018-07-11 |
美商帝國製藥美國股份有限公司 |
包含右美托嘧啶（ｄｅｘｍｅｄｅｔｏｍｉｄｉｎｅ）經皮組成物之疼痛處理用方法及組成物
|
|
RU2648817C2
(ru)
|
2013-10-07 |
2018-03-28 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Способы и композиции для лечения абстинентных синдромов с использованием неседативных трансдермальных композиций на основе дексмедетомидина
|
|
KR20180095732A
(ko)
|
2013-10-07 |
2018-08-27 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
|
|
WO2015069778A1
(en)
|
2013-11-05 |
2015-05-14 |
The General Hospital Corporation |
System and method for determining neural states from physiological measurements
|
|
US11033493B2
(en)
|
2013-12-02 |
2021-06-15 |
Intelgenx Corp. |
Film dosage form with extended release mucoadhesive particles
|
|
WO2015093503A1
(ja)
|
2013-12-18 |
2015-06-25 |
丸石製薬株式会社 |
含水型貼付剤
|
|
US20170274174A1
(en)
|
2014-08-22 |
2017-09-28 |
The General Hospital Corporation |
System and method for administering, monitoring and controlling biomimetic sleep
|
|
WO2016029211A1
(en)
|
2014-08-22 |
2016-02-25 |
The General Hospital Corporation |
Systems and methods for discovery and characterization of neuroactive drugs
|
|
US9726337B2
(en)
*
|
2014-08-27 |
2017-08-08 |
R. W. Swarens Associates, Inc. |
Light fixture for indirect asymmetric illumination with LEDs
|
|
CN104161760A
(zh)
|
2014-09-01 |
2014-11-26 |
西北农林科技大学 |
一种貉用复合麻醉剂及其制备方法和应用
|
|
MA41689A
(fr)
|
2014-10-15 |
2017-08-22 |
Bioxcel Corp |
Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
|
|
WO2016061554A1
(en)
*
|
2014-10-16 |
2016-04-21 |
Bioxcel Corporation |
Synergistic composition of known, safe pharmaceuticals for use in insomnia and a method of treatment thereof
|
|
FI127534B
(en)
|
2014-11-10 |
2018-08-31 |
Vetcare Oy |
Substituted benzoefuroquinolizine and ɑ2-adrenergic agonist comprising compositions
|
|
WO2016089997A1
(en)
|
2014-12-02 |
2016-06-09 |
Yale University |
Methods of preventing neurodegeneration of association cortex in a mammal
|
|
JP2016154598A
(ja)
|
2015-02-23 |
2016-09-01 |
ニプロ株式会社 |
デクスメデトミジン注射液を充填したプレフィルドシリンジ
|
|
CN104784174A
(zh)
|
2015-03-06 |
2015-07-22 |
北京大学第一医院 |
右美托咪定的药物新用途
|
|
US11160901B2
(en)
|
2015-04-10 |
2021-11-02 |
Tricol Biomedical, Inc. |
Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical field
|
|
CN106038538A
(zh)
|
2015-04-17 |
2016-10-26 |
江苏恒瑞医药股份有限公司 |
一种右美托咪定的预混合制剂
|
|
US10179136B2
(en)
|
2015-06-19 |
2019-01-15 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for anesthesiological applications
|
|
US20160374588A1
(en)
|
2015-06-24 |
2016-12-29 |
Microsoft Technology Licensing, Llc |
Monitoring hydration based on galvanic skin response
|
|
CN105168122B
(zh)
|
2015-09-24 |
2018-11-27 |
辰欣药业股份有限公司 |
一种盐酸右美托咪定注射液及其制备工艺
|
|
US20170128421A1
(en)
|
2015-11-11 |
2017-05-11 |
Siva Prasad Reddy Sura |
Premix formulation for parenteral use and packaging thereof
|
|
US10632043B2
(en)
|
2015-11-11 |
2020-04-28 |
Aurobindo Pharma Ltd |
Premix formulation for parenteral use and packaging thereof
|
|
JP6895455B2
(ja)
|
2016-01-04 |
2021-06-30 |
ジュロックス ピーティーワイ リミテッドＪｕｒｏｘ Ｐｔｙ Ｌｔｄ |
薬剤放出デバイス及び使用
|
|
CN105534891A
(zh)
|
2016-01-18 |
2016-05-04 |
南京正科医药股份有限公司 |
一种盐酸右美托咪定注射液
|
|
US9949934B1
(en)
|
2016-10-20 |
2018-04-24 |
Intelgenx Corp. |
Device and method of treating conditions associated with neuroinflammation
|
|
US9717796B1
(en)
|
2016-04-20 |
2017-08-01 |
Slypharma, Llc |
Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
|
|
CN107412152B
(zh)
|
2016-05-24 |
2020-12-04 |
海南合瑞制药股份有限公司 |
一种盐酸右美托咪定注射液组合物
|
|
WO2017213977A1
(en)
|
2016-06-07 |
2017-12-14 |
Mehra Akhil |
Methods and compositions for the treatment of trauma and stressor-related disorders
|
|
CN105997955B
(zh)
|
2016-06-28 |
2017-09-12 |
力品药业（厦门）有限公司 |
一种帕洛诺司琼口腔膜剂及其制备方法
|
|
RU2635532C1
(ru)
|
2016-09-06 |
2017-11-13 |
Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации |
Способ профилактики ажитационного синдрома у детей с онкологической патологией
|
|
JP7073358B2
(ja)
|
2016-10-12 |
2022-05-23 |
ピー・エス・セラピー・リミテッド |
人工涙液、コンタクトレンズ及び薬剤担体組成物並びにその使用方法
|
|
AU2017342160A1
(en)
|
2016-10-13 |
2019-05-23 |
Catalent U.K. Swindon Zydis Limited |
Lyophilized pharmaceutical compositions for vaginal delivery
|
|
EP3532035B1
(en)
|
2016-10-25 |
2023-06-07 |
Catalent U.K. Swindon Zydis Limited |
Compositions of different densities for fast disintegrating multi-layer tablet
|
|
US20180147201A1
(en)
|
2016-10-31 |
2018-05-31 |
Allodynic Therapeutics, Llc |
Combinations of opioid/tlr4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
|
|
BR112019006955A2
(pt)
|
2016-10-31 |
2019-07-02 |
Teikoku Pharma Usa Inc |
métodos de controle da dor usando dispositivos de distribuição transdérmica de dexmedetomidina
|
|
CN106727524A
(zh)
|
2016-11-08 |
2017-05-31 |
叶茂 |
一种药物组合物及其应用
|
|
CN106539778A
(zh)
|
2016-12-08 |
2017-03-29 |
武汉大学 |
一种小儿麻醉术前含服口腔泡腾片及其制备方法
|
|
CN106727443A
(zh)
|
2016-12-08 |
2017-05-31 |
武汉大学 |
一种小儿麻醉术前镇静的隐形鼻贴制剂及其制备方法
|
|
KR20190096376A
(ko)
|
2016-12-13 |
2019-08-19 |
오리온 코포레이션 |
개에서의 분리 불안의 치료에 사용하기 위한 덱스메데토미딘 또는 메데토미딘
|
|
WO2018116202A1
(en)
|
2016-12-20 |
2018-06-28 |
Azista Industries Pvt Ltd |
Stabilized mouth freshener strips
|
|
SG10202107367SA
(en)
|
2016-12-31 |
2021-08-30 |
Bioxcel Therapeutics Inc |
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
EP3592427A1
(fr)
|
2017-03-07 |
2020-01-15 |
Childs, Marc |
Prevention des risques associes à un allongement de l'intervalle qt d'origine medicamenteuse à l'aide d'un inhibiteur specifique de la production de ros d'origine mitochondriale
|
|
CN107137399A
(zh)
|
2017-04-24 |
2017-09-08 |
徐颖 |
一种用于麻醉的舌下片及其制备方法
|
|
CN107412204A
(zh)
|
2017-04-24 |
2017-12-01 |
重庆医科大学附属儿童医院 |
一种用于麻醉的干粉吸入剂及其制备方法
|
|
CN107693485A
(zh)
|
2017-04-24 |
2018-02-16 |
重庆医科大学附属儿童医院 |
一种用于麻醉的滴鼻液及其制备方法
|
|
CN107028880A
(zh)
|
2017-06-09 |
2017-08-11 |
安徽赛诺制药有限公司 |
一种盐酸右美托咪定注射液的生产工艺
|
|
EP3668488A4
(en)
|
2017-08-15 |
2021-03-24 |
The Board of Trustees of the Leland Stanford Junior University |
POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG RELEASE
|
|
IL272220B2
(en)
|
2017-08-20 |
2024-05-01 |
Formulex Pharma Innovations Ltd |
Preparations in the form of dry powder to be administered into the nose
|
|
US11857334B2
(en)
|
2017-10-04 |
2024-01-02 |
The General Hospital Corporation |
Systems and methods for monitoring a subject under the influence of drugs
|
|
US20190216345A1
(en)
|
2017-10-18 |
2019-07-18 |
Christoper Scheib |
Method and system for monitoring and displaying physiological conditions
|
|
US11147459B2
(en)
|
2018-01-05 |
2021-10-19 |
CareBand Inc. |
Wearable electronic device and system for tracking location and identifying changes in salient indicators of patient health
|
|
US11406316B2
(en)
|
2018-02-14 |
2022-08-09 |
Cerenion Oy |
Apparatus and method for electroencephalographic measurement
|
|
WO2019171173A1
(en)
|
2018-03-08 |
2019-09-12 |
Catalent U.K. Swindon Zydis Limited |
Process to reduce endotoxin in gelatin
|
|
KR20190109310A
(ko)
|
2018-03-15 |
2019-09-25 |
주식회사 바이오홀딩스 |
레반을 함유하는 염증성 질환 치료용 경비투여형 스프레이 제제
|
|
CN108498469A
(zh)
|
2018-05-30 |
2018-09-07 |
宁波蒙曼生物科技有限公司 |
盐酸右美托咪定冻干粉及其制备方法
|
|
BR112020026672A2
(pt)
|
2018-06-27 |
2021-03-30 |
Bioxcel Therapeutics, Inc. |
Formulações de filme contendo dexmedetomidina e métodos para produzi-las
|
|
EP3813828A4
(en)
|
2018-06-27 |
2022-03-30 |
Bioxcel Therapeutics, Inc. |
METHOD OF TREATMENT OF AGITATION WITH DEXMEDETOMIDIN HYDROCHLORIDE
|
|
WO2020006073A1
(en)
|
2018-06-28 |
2020-01-02 |
Arx, Llc |
Dispensing method for producing dissolvable unit dose film constructs
|
|
CN110893186A
(zh)
|
2018-09-12 |
2020-03-20 |
宜昌人福药业有限责任公司 |
一种药物组合物及其制备方法和用途
|
|
JP2019048091A
(ja)
|
2018-10-23 |
2019-03-28 |
ニプロ株式会社 |
デクスメデトミジン注射液を充填したプレフィルドシリンジ
|
|
KR102183744B1
(ko)
|
2018-11-26 |
2020-11-27 |
연세대학교 산학협력단 |
섬망 발병 위험도의 예측 방법 및 이를 이용한 디바이스
|
|
CN109620802A
(zh)
|
2018-12-05 |
2019-04-16 |
杜皓 |
一种麻醉用鼻喷剂及其制备方法
|
|
CN111481506B
(zh)
|
2019-01-25 |
2023-01-24 |
江苏恒瑞医药股份有限公司 |
一种包含经鼻给药的右美托咪定组合物的药物制品
|
|
US10900762B2
(en)
|
2019-02-21 |
2021-01-26 |
Aob Products Company |
Ammunition press and components thereof
|
|
WO2020259440A1
(zh)
|
2019-06-28 |
2020-12-30 |
四川普锐特药业有限公司 |
右美托咪定鼻喷剂、其制备方法及应用
|
|
CN116474218A
(zh)
|
2019-06-28 |
2023-07-25 |
四川普锐特药业有限公司 |
保持给药均一度的药物流体分配器及右美托咪定鼻喷器
|
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
|
CA3154659A1
(en)
|
2019-09-18 |
2021-03-25 |
Bioxcel Therapeutics, Inc. |
Systems and methods for detection and prevention of emergence of agitation
|
|
EP4104062A4
(en)
|
2020-02-14 |
2024-04-24 |
Bioxcel Therapeutics, Inc. |
SYSTEMS AND METHODS FOR DETECTING AND PREVENTING THE APPEARANCE OF AGITATION
|
|
MX2023003993A
(es)
|
2020-10-08 |
2023-05-24 |
Bioxcel Therapeutics Inc |
Tratamiento de trastornos bipolares y psicosis con clorhidrato de dexmedetomidina.
|
|
MX2023007998A
(es)
|
2021-01-04 |
2023-08-08 |
Bioxcel Therapeutics Inc |
Regimenes de tratamiento con dexmedetomidina.
|
|
EP4297871A4
(en)
|
2021-02-26 |
2025-01-01 |
BioXcel Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR TREATING AGITATION
|